Michael Raab - Director at Amicus Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
FOLD on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael Raab since 9/18/2023

Holdings reported by Michael Raab for Amicus Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 95.4K $954K $10.00 Jun 6, 2024 Direct
Stock Options (right to buy) 42.5K Jun 6, 2024 Direct Common Stock

Transactions reported by Michael Raab for Amicus Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.